Zai Lab Limited (ZLAB)
NASDAQ: ZLAB · IEX Real-Time Price · USD
18.66
-0.14 (-0.74%)
At close: Jul 19, 2024, 4:00 PM
18.65
-0.01 (-0.05%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Zai Lab Market Cap
Zai Lab has a market cap or net worth of $1.85 billion as of July 22, 2024. Its market cap has decreased by -32.63% in one year.
Market Cap
1.85B
Enterprise Value
1.15B
1-Year Change
-32.63%
Ranking
Category
Stock Price
$18.66
Market Cap Chart
Since September 20, 2017, Zai Lab's market cap has increased from $1.37B to $1.85B, an increase of 35.00%. That is a compound annual growth rate of 4.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.85B | -31.47% |
| Dec 29, 2023 | 2.70B | -10.13% |
| Dec 30, 2022 | 3.01B | -50.39% |
| Dec 31, 2021 | 6.06B | -39.37% |
| Dec 31, 2020 | 9.99B | 311.80% |
| Dec 31, 2019 | 2.43B | 106.75% |
| Dec 31, 2018 | 1.17B | 12.73% |
| Dec 29, 2017 | 1.04B | -23.99% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Warby Parker | 1.88B |
| Mirum Pharmaceuticals | 1.86B |
| Verona Pharma | 1.86B |
| NeoGenomics | 1.85B |
| Akero Therapeutics | 1.85B |
| RxSight | 1.82B |
| Harmony Biosciences Holdings | 1.82B |
| Neumora Therapeutics | 1.80B |